# Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans

> **NCT04769206** · PHASE1,PHASE2 · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 160 (estimated)

## Conditions studied

- Endothelial Dysfunction

## Interventions

- **DRUG:** Galantamine
- **DRUG:** Placebo
- **DEVICE:** TENS 7000

## Key facts

- **NCT ID:** NCT04769206
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-20
- **Primary completion:** 2027-05-31
- **Final completion:** 2028-06-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04769206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04769206, "Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04769206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*